ImmunoACT
Atharva Karulkar is a co-founder of ImmunoACT, having been with the company since October 2018. Prior to this role, Atharva Karulkar was a doctoral student at the Indian Institute of Technology, Bombay from June 2015 to July 2022, where a Doctor of Philosophy in Immunology was earned. Atharva Karulkar's academic and professional experience is rooted in immunology, showcasing a commitment to advancement in this field.
ImmunoACT
Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer in the development of the country's first indigenous Cell & Gene Therapy. With a rapidly expanding pipeline beginning with blood cancers, our mission is to provide affordable access to novel autologous CAR-T cell therapies.